Health Products

BILD2 and BILIRUBIN TOTAL GEN.3 (2016-07-20)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
All lots
Manufacturer
Roche Diagnostics GMBH
Sandhoferstrasse 116
Mannheim
68305
GERMANY
B. BILIRUBIN TOTAL GEN.3 (BILT3)05795320190
All lots
Manufacturer
Roche Diagnostics GMBH
Sandhoferstrasse 116
Mannheim
68305
GERMANY
A. BILD2 (DIRECT BILIRUBIN GEN.2)05168384190

Introduction

Affected products

A. BILD2 (DIRECT BILIRUBIN GEN.2)
B. BILIRUBIN TOTAL GEN.3 (BILT3)

Reason

This recall/product correction is related to a new drug interference that was identified for Indocynanine Green (ICG) in all direct and total bilirubin tests performed on Roche platforms (cobas c. COBAS INTEGRA, and modular p systems).
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime